|2005N-0354||Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing|
|FDA Comment Number :||EC90|
|Submitter :||Mr. John Pantermuehl||Date & Time:||12/07/2005 06:12:40|
|Organization :||Mr. John Pantermuehl|
|Category :||Individual Consumer|
| FDA should mandate that drug companies provide clinical proof of chemical imbalance before allowing claims to be made that these drugs correct chemical imbalance.
If this is not forthcoming, advertisements of drugs to correct a condition that has not been proven to exist should explicitly state this.